Our Lab Research

Research in our lab is focused on two specific areas:

1. Understanding (i) how the inflammatory reaction modulates the AHR-regulated genes, and (ii) the role of coregulatory (coactivator and corepressor) proteins and the interaction between inflammation and the AHR in the regulation of AHR-regulated genes. These studies will a) increase our knowledge about the regulation of the AHR-regulated genes during inflammation and shall detail the signalling pathways and mechanisms underlying the modulation of the AHR-regulated genes, and b) provide information that will make drug usage safer by decreasing the incidence of adverse effects. This will help to diminish health care costs, as well as to design strategies that improve treatment of inflammation-dependent illnesses and disorders.

CYP1A1 Induction

Whitlock JP Jr., Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol  1999;39:103-25

2. Understanding (i) the potential interaction between heavy metals and AHR ligands which are common in the environment on the regulation of AHR-regulated genes, and (ii) investigate the effects of AHR ligand/metal mixtures on AHR ligands-mediated mutagenicity and carcinogenicity. These studies will a) increase our knowledge about the effect of heavy metals on the AHR-regulated genes, and b) provide the information that will help to design strategies to improve treatment of AHR ligands mediated mutagenicity and carcinogenicity.

 

                     © 2003, Drug Metabolism & Pharmacokinetics